...Emerging market report 2007 Disclaimer PricewaterhouseCoopers has exercised professional care and diligence in the collection and processing of the information in this report. However, the data used in the preparation of this report (and on which the report is based) was provided by third-party sources. This report is intended to be of general interest only and does not constitute professional advice. PricewaterhouseCoopers makes no representations or warranties with respect to the accuracy of this report. PricewaterhouseCoopers shall not be liable to any user of this report or to any other person or entity for any inaccuracy of information contained in this report or for any errors or omissions in its content, regardless of the cause of such inaccuracy, error or omission. Furthermore, to the extent permitted by law, PricewaterhouseCoopers, its members, employees and agents accept no liability and disclaim all responsibility for the consequences of you or anyone else acting, or refraining from acting, in relying upon the information contained in this report or for any decision based on it, or for any consequential, special, incidental or punitive damages to any person or entity for any matter relating to this report even if advised of the possibility of such damages. The member firms of the PricewaterhouseCoopers network (www.pwc. com) provide industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders...
Words: 6564 - Pages: 27
...Should Bella Healthcare India take on Project TKO and develop an EKG specifically for the local market? Why or why not? TKO, “Technical Knockout”, is single channel EKG, Bella Healthcare India is planning to launch in Indian market. As per my opinion, Bella has many reasons to take up this opportunity. I will categorise these reasons in two broad categories, External and Internal factors. First external factor that affects decision of Bella to take TKO is large population of India with insufficient health care services. India’s population is large and growing but healthcare facilities are not growing with the same rate. Also most of the medical facilities of the country are concentrated in urban areas, leaving rural area with insufficient healthcare facilities. Unfortunately, most of the Indian population stays in small towns and villages. Another fact, in line with this, is availability of less no of physicians and specialists in the field of heart diseases. This has created room for medical services and devices sellers to expand their businesses in the country. The EKG global revenue chart shows that between 2010 and 2015, 9% – 12% of the global revenue will come from Asia-Pacific. As one of the second highest population country in Asia-Pacific, India will definitely contribute major portion of the revenue. The figures in the chart substantiate the fact that Bella has good scope to expand its services in the country. Second factor that helps Bella to take go ahead decision...
Words: 1387 - Pages: 6
...Industry Insight – Indian Diagnostic & Pathology Test Laboratory Indian Diagnostic & Pathology Test Laboratory Industry Insight April 2009 4th & 5th Floors, Astral Heights, Road No. 1, Banjara Hills, Hyderabad-500034, India Tel: +91-40-23430203-05, Fax: +91-40-23430201, E-mail: info@cygnusindia.com Website: www.cygnusindia.com Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Cygnus Business Consulting & Research Pvt. Ltd. (Cygnus). While reasonable care has been taken in its preparation, Cygnus makes no representation or warranty, express or implied, as to the accuracy, timeliness or completeness of any such information. The information contained herein may be changed without notice. All information should be considered solely as statements of opinion and Cygnus will not be liable for any loss incurred by users from any use of the © Cygnus Business Consulting & Research Pvt. Ltd. 2009 2 publication or contents Industry Insight – Indian Diagnostic & Pathology Test Laboratory SYNOPSIS According to Cygnus estimates, the Indian diagnostic and pathological labs test services market was valued at Rs66.87 billion in FY2008. Indian diagnostics and pathological labs, based on the working level, are classified into high-end labs, accounting for 38% of the market share, manual labs (28%) and second-level regional labs (34%). By therapeutic segment, the major share is held by biochemistry (38%), followed by...
Words: 1239 - Pages: 5
... ROLL: 19 SEMESTER: 6 COURSE: BACHELOR IN BUSINESS ADMINISTRATION TOPIC: PRIVATISATION IN THE INDIAN HEALTHCARE SECTOR CONTENTS 1. INTRODUCTION 1.1. PRIVATIZATION 1.2 INDIAN HEALTHCARE INDUSTRY 1.2.1 DRIVERS FOR GROWTH OF HEALTHCARE 1.3 PUBLIC HEALTHCARE IN INDIA 1.4 PRIVATE SECTOR IN THE INDIAN HEALTHCARE DELIVERY SYSTEM 1.4.1 GOVERNMENT POLICIES TO SUPPORT THE GROWTH OF PRIVATE SECTOR 1.4.2 FDI IN THE INDIAN HEALTHCARE 1.4.2.1 STATUS AND PROSPECTS FOR FOREIGN INVESTMENTS IN HOSPITALS IN INDIA 1.4.2.2 CONSTRAINTS TO FOREIGN INVESTMENTS IN HOSPITALS IN INDIA 1.4.2.3 FOREIGN PRESENCE IN HOSPITALS IN INDIA 1.4.2.4 SUMMARY OF PROS AND CONS FOR FINANCING SOURCES OF HOSPITALS OBJECTIVES 2. LITERATURE REVIEW 3. ANALYSIS OF THE IMPACT OF PRIVATIZATION IN THE HEALTHCARE SECTOR 3.1 QUALITY AND PRIVATE HEALTHCARE SERVICES 3.2 IMPACT OF FOREIGN INVESTMENTS IN HOSPITALS IN INDIA 3.3 CONSUMER PERCEPTION OF PRIVATE SECTOR 3.4 EMERGING TRENDS IN HOSPITALS IN INDIA: CHALLENGES AND INTERVENTIONS 4. CONCLUSION 5. ACKNOWLEDGEMENT 6. BIBLIOGRAPHY ...
Words: 9237 - Pages: 37
...Company Name : Abbott India Assignment 2- Overview of the Industry (a) Degree of competitiveness in the industry; The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. Following the de-licensing of the pharmaceutical industry, industrial licensing for most of the drugs and pharmaceutical products has been done away with. Manufacturers are free to produce any drug duly approved by the Drug Control Authority. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific...
Words: 1006 - Pages: 5
...Indian Institute of foreign trade | Critical Analysis | Identifying International Marketing Opportunities in Medical Services | 04-Nov-12 | Background Medical tourism is becoming a popular option for tourists across the globe. It includes primarily and predominantly healthcare facilities, combined with travel and tourism. The term medical tourism describes the rapidly growing practice of travelling across international borders to obtain cost-effective and high quality medical care. Various countries like Thailand, Malaysia, India, etc are promoting medical tourism aggressively. The key competitive advantages of India in medical tourism stem from the following: low cost advantage, strong reputation in the advanced healthcare segment (cardiovascular surgery, organ transplants, eye surgery etc.) and the diversity of tourist destinations available in the country. The key concerns facing the industry include: absence of government initiative, lack of a coordinated effort to promote the industry, no accreditation mechanism for hospitals and the lack of uniform pricing policies and standards across hospitals. Medical tourism or health care tourism is a rapidly growing multibillion-dollar industry around the world. It is an economic activity that comprises trade in medical services and represents the mixing of two of the largest world industries: medicine and tourism. The case identifies the strengths of India’s medical tourism service providers and points at a number of problems...
Words: 2665 - Pages: 11
...shrine at bath, a practice that continued for 2,000 years. During 18th century wealthy Europeans used to visit health resorts in North Africa. But in the past seven years or so, the movement has accelerated sharply. It is growing rapidly and turning out to be an immense business opportunity for nations which have the strategic advantage of having resources in terms of medical technology, infrastructure and right human resources. Cross-border travel for health reasons is a $40 billon market and growing at over 15% a year throws up huge opportunities for anyone smart enough to tap it. Broadly defined as a collaboration of medical services with the tourism industry, healthcare tourism offers cost effective medical services for individuals who cannot afford these services in their country due to high costs or to people who are tired by long waiting times. Also patients from countries, where treatment is not available, can avail the benefits of healthcare tourism. Countries that are actively promoting healthcare tourism include Belgium, Singapore, Malaysia, India, Thailand, Cuba, Costa Rica, Hungary, and Poland. Greece and South Africa are also emerging as new destinations. India is the latest entrant in the field of health tourism. The WTO identified four modes that will help boost trade in health care services worldwide. Medical travel is the most visible face of the increasing global trade in health care services. The other three modes are Cross border delivery of trade The...
Words: 2679 - Pages: 11
...Industry Snapshot The Indian pharmaceutical industry is highly dynamic and offers great opportunities for both domestic and foreign companies. The industry is estimated to have generated revenue worth US$ 13.1 billion in FY 2011, according to a new Research and Market’s report, “Indian Pharma Sector Forecast 2014.” India will emerge as a leading global player in pharmaceutical industry by 2020, securing a place among the top five major global markets, according to Ikon Marketing Consultant (IMC). Also, Associated Chambers of Commerce and Industry (Assocham) has said it expects the Indian pharmaceutical industry to reach US$ 20 billion by 2015, making it one of the world's top 10 pharmaceuticals markets. India has a strong local manufacturing base and domestic players are developing substantial international presence. Healthcare is also one of the largest service sector industries in India, in terms of revenue and employment. Rising health awareness and increasing government expenditure on healthcare sector is driving growth in the sector. Medical tourism and health insurance are also on a rise, with significant growth in healthcare sector and establishment of large number of hospitals, both public and private. The Indian healthcare industry, estimated at US$ 50 billion, is expected to reach over US$ 75 billion by 2012, and US$ 100 billion by 2015. Talent Challenges While specialised talent is critical for any knowledge industry, it is more so within the pharmaceuticals industry...
Words: 6445 - Pages: 26
...Describe the Situation Sector Bella Healthcare was founded in 1960 as a manufacturing of Holter monitors. Due to the advent of transistors by early 1960’s, Bella Healthcare had become widely accepted for clinical use. Bella Healthcare India was originally established in Bangalore as a low-cost manufacturing facility for a U.S.-based cardiology equipment developer. The company was launched with The Bella brothers developed version of Holter that was more comfortable for patients and more reliable than competing device. As the year goes by the company expanded its offering to a range of cardiology equipment. Bella Healthcare wanted to establish an Asian Manufacturing location in addition to its facility outside St. Louis, after accessing several location there was a strong recommendation to select Bangalore. Bella had sales office in Europe and Asian Market but this would be the first manufacturing facility outside the US. Bella Healthcare India started operation in 1990s. Bella India is bent on achieving goals and innovation of health facilities. The Bangalore facility products were lower cost but also of high quality. Strategic Aim The establishment of an Asian manufacturing location in addition to Bella’s Facility outside US was succeeded by the Bella healthcare India. The immediate goal was to establish a lean low cost manufacturing facility in India. In 1990 operation at Bella Healthcare India started with the assembly and testing of EKG electrodes and amplifies....
Words: 1493 - Pages: 6
...Indian Pharma Industry – an overview April 13, 2012 The demand for pharmaceutical products in India is significant and is driven by low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration etc. The Indian pharmaceutical industry is growing at about 8 to 9 percent annually according to “A Brief Report Pharmaceutical Industry in India,” published in January 2011. The Pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are approximately 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). I. Current Scenario: India's pharmaceutical market grew at 15.7 per cent during December 2011. Globally, Indiaranks third in terms of manufacturing pharma products by volume. According to McKinsey, the Pharmaceutical Market is ranked 14th in the world. By 2015 it is expected to reach top 10 in the world beating Brazil, Mexico, South Korea and Turkey. More importantly, the incremental market growth of US$ 14billion over the next decade is likely to be the third largest among all markets. The US and China are expected to add US$ 200bn and US$ 23bn respectively. McKinsey & Company’s report, “India Pharma 2020:...
Words: 1969 - Pages: 8
...Emerging Trends in Healthcare A Journey from Bench to Bedside 17 February 2011 © 2011 KPMG, an Indian Partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. Acknowledgement India’s competitive advantage lies in the lower production and research cost, its large pool of low cost technical and scientifically trained personnel, and large number of compliance certified manufacturers and service providers, which make us different from others. ASSOCHAM feels that technology incubation is no longer confined to a few institutions; it is a responsibility that we have to share, if we wish to see a better and a healthy future ahead. There is an immense need to develop skilled manpower in the area of healthcare and modern as well as traditional medicines. I am glad that this Summit on Emerging trends in Healthcare will bring forth the journey from research desk to the bedside of patient, as we will look at healthcare at the frontline to identify some common challenges that may help explain the complex nature of healthcare and the scale of the “change” challenge. I wish to thank KPMG for unanimously contributing towards this Knowledge Paper, which gives a rich and comprehensive insight of the trend in healthcare. I would also take the opportunity to thank QCI for supporting this event. The case studies contributed providing the best of...
Words: 17817 - Pages: 72
...Healthcare in India follows universal healthcare system run by the constituent states and territories if India. Every state in India promotes health and wellness by raising the level of nutrition and standard of living of its people and improves public health. Government hospitals, some of which are among the best hospitals in India, provide treatment at taxpayer expense where drugs are offered free of charge in these hospitals. Government hospitals provide treatment either free or at minimal charges. For example, according to Wikipedia, For example, an outpatient card at AIIMS (one of the best hospitals in India) costs a one-time fee of rupees 10 (around 20 cents US) and thereafter outpatient medical advice is free. In-hospital treatment costs depend on financial condition of the patient and facilities utilized by him but are usually much less than the private sector. For instance, a patient is waived treatment costs if he is below poverty line. Another patient may seek for an air-conditioned room if he is willing to pay extra for it. The charges for basic in-hospital treatment and investigations are much less compared to the private sector. The cost for these subsidies comes from annual allocations from the central and state governments. In the greater India, the hospitals are run by government, charitable trusts and by private organizations. The government hospitals in rural areas are called the (PHC) primary health center. Major hospitals are located in district head quarters...
Words: 1705 - Pages: 7
...Influence of the American healthcare system on Indian health services USA is the world’s largest economy. Its dominance in the sphere of arts, science, technology, culture and medicine is unparalleled today. Given its dominant socio-political and economic status, no country on earth can be said to be beyond the sphere of American influence in almost all aspects of life. While the pervasiveness of such American hegemony is a matter of debate today in many sociological discourses today, for the purpose of this paper, we will concentrate on influence of American healthcare on the healthcare system of India. The American way of life is typified by the example of “rugged individualism,” where each individual works to secure their own interest....
Words: 2744 - Pages: 11
...The strong growth of Indian economy also boosts country’s healthcare industry. According to Indian Brand Equity Foundation (IBEF), the Indian healthcare industry is worth around US$ 100 billion and is expected to grow to US$ 280 billion by 2020. This in turn creates a huge demand for electronic components, devices and products which are used for medical purpose. Medical electronics technology has reinforced the existing healthcare infrastructure in various ways right from digitizing medical test, diagnostic and therapeutic procedures to enhancing the reach of healthcare through telemedicine and Health IT. India as an emerging market continues to be relevant in the global medical electronics space, not just from a market point of view, but also as a global hub for innovation and manufacturing. A rise in the number of hospitals and the increased requirement for healthcare facilities creates a need for sophisticated devices and equipment, which can provide accurate treatment to individuals. The Medical Electronics segment of this industry incorporates control, conversion, sensing, processing, storage, display, and transfer of information on anatomy and physiology by making use of the Electronics and Communication Technologies. Medical Electronics is an area,...
Words: 710 - Pages: 3
...Repositioning Strategy for Indian Pharmaceutical Companies in Global Context Submitted to PROFESSOR MURALI PATIBANDLA (FACULTY,CORPORATE STRATEGY AND POLICY) Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ................................................................................................................................................. 6 Indian Pharma Industry.............
Words: 7934 - Pages: 32
